Boston Common Asset Management, LLC Novozymes A/S Sponsored Adr (D Transaction History

Boston Common Asset Management, LLC

$1.7 Billion
Q1 2025

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$60.61 - $72.03 $29,941 - $35,582	-494 Reduced 10.71%	4,119 $297,000
Q2 2024 Jul 08, 2024	SELL	$54.21 - $63.59 $40,169 - $47,120	-741 Reduced 13.84%	4,613 $282,000
Q1 2024 Apr 11, 2024	SELL	$50.49 - $61.73 $5,452 - $6,666	-108 Reduced 1.98%	5,354 $314,000
Q4 2023 Jan 09, 2024	SELL	$38.77 - $55.49 $512,965 - $734,188	-13,231 Reduced 70.78%	5,462 $300,000
Q3 2023 Oct 11, 2023	BUY	$39.7 - $50.74 $7,662 - $9,792	193 Added 1.04%	18,693 $756,000
Q2 2023 Jul 24, 2023	SELL	$46.04 - $54.69 $11,279 - $13,399	-245 Reduced 1.31%	18,500 $862,000
Q1 2023 May 17, 2023	BUY	$47.3 - $52.94 $15,703 - $17,576	332 Added 1.8%	18,745 $959,000
Q4 2022 Jan 26, 2023	BUY	$47.06 - $60.8 $46,965 - $60,678	998 Added 5.73%	18,413 $930,000
Q3 2022 Oct 20, 2022	SELL	$48.38 - $63.99 $32,511 - $43,001	-672 Reduced 3.72%	17,415 $879,000
Q2 2022 Aug 10, 2022	BUY	$55.8 - $70.04 $490,147 - $615,231	8,784 Added 94.42%	18,087 $1.08 Million
Q1 2022 May 16, 2022	SELL	$57.93 - $81.66 $61,869 - $87,212	-1,068 Reduced 10.3%	9,303 $0
Q4 2021 Jan 31, 2022	BUY	$66.41 - $83.12 $41,439 - $51,866	624 Added 6.4%	10,371 $0
Q3 2021 Nov 12, 2021	BUY	$68.4 - $80.96 $39,672 - $46,956	580 Added 6.33%	9,747 $668,000
Q2 2021 Aug 19, 2021	BUY	$62.84 - $75.74 $85,211 - $102,703	1,356 Added 17.36%	9,167 $0
Q1 2021 May 14, 2021	BUY	$56.41 - $66.23 $160,260 - $188,159	2,841 Added 57.16%	7,811 $0
Q4 2020 Feb 05, 2021	BUY	$54.99 - $65.67 $42,067 - $50,237	765 Added 18.19%	4,970 $286,000
Q3 2020 Nov 10, 2020	SELL	$57.4 - $65.98 $2,410 - $2,771	-42 Reduced 0.99%	4,205 $265,000
Q2 2020 Aug 10, 2020	BUY	$44.77 - $58.07 $190,138 - $246,623	4,247 New	4,247 $245,000
Q4 2019 Jan 28, 2020	SELL	$40.36 - $49.32 $861,040 - $1.05 Million	-21,334 Closed	0 $0
Q3 2019 Nov 07, 2019	SELL	$42.06 - $44.29 $136,400 - $143,632	-3,243 Reduced 13.2%	21,334 $897,000
Q2 2019 Jul 26, 2019	SELL	N/A	-1,608 Reduced 6.14%	24,577 $1.15 Million
Q1 2019 May 03, 2019	BUY	N/A	3,618 Added 16.03%	26,185 $1.21 Million
Q4 2018 Jan 25, 2019	BUY	N/A	3,911 Added 20.96%	22,567 $1.01 Million
Q3 2018 Nov 01, 2018	BUY	N/A	1,014 Added 5.75%	18,656 $1.03 Million
Q2 2018 Aug 06, 2018	SELL	N/A	-4,640 Reduced 20.82%	17,642 $895,000
Q1 2018 Apr 26, 2018	BUY	N/A	2,139 Added 10.62%	22,282 $1.15 Million
Q4 2017 Feb 07, 2018	SELL	N/A	-2,151 Reduced 9.65%	20,143 $1.15 Million
Q3 2017 Nov 13, 2017	SELL	N/A	-9 Reduced 0.04%	22,294 $1.14 Million
Q2 2017 Aug 14, 2017	BUY	N/A	22,303	22,303 $975,000

Others Institutions Holding NVZMY

# of Institutions

Shares Held

131K

Call Options Held

Put Options Held

View Full List

About NOVOZYMES A/S SPONSORED ADR (D

Ticker NVZMY
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 276,303,008
Market Cap $17.2B

More about NVZMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Common Asset Management, LLC with notifications on news.

Account